Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 15500894)

1.

Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.

Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, van Lanschot JJ, Wijrdeman HK, Mulder CJ, Reinders JG, Boot H, Aleman BM, Kuipers EJ, Siersema PD.

Lancet. 2004 Oct 23-29;364(9444):1497-504.

PMID:
15500894
2.

[Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study].

Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, van Lanschot JJ, Wijrdeman HK, Mulder CJ, Reinders JG, Boot H, Aleman BM, Kuipers EJ, Siersema PD.

Ned Tijdschr Geneeskd. 2005 Dec 10;149(50):2800-6. Dutch.

PMID:
16385833
3.

Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer.

Polinder S, Homs MY, Siersema PD, Steyerberg EW; Dutch SIREC Study Group.

Br J Cancer. 2004 Jun 1;90(11):2067-72.

4.

Interventions for dysphagia in oesophageal cancer.

Dai Y, Li C, Xie Y, Liu X, Zhang J, Zhou J, Pan X, Yang S.

Cochrane Database Syst Rev. 2014 Oct 30;10:CD005048. doi: 10.1002/14651858.CD005048.pub4. Review.

PMID:
25354795
5.

Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy.

Homs MY, Essink-Bot ML, Borsboom GJ, Steyerberg EW, Siersema PD; Dutch SIREC Study Group.

Eur J Cancer. 2004 Aug;40(12):1862-71.

PMID:
15288288
6.

Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.

Hirdes MM, van Hooft JE, Wijrdeman HK, Hulshof MC, Fockens P, Reerink O, van Oijen MG, van der Tweel I, Vleggaar FP, Siersema PD.

Gastrointest Endosc. 2012 Aug;76(2):267-74. doi: 10.1016/j.gie.2012.04.442. Epub 2012 Jun 12.

PMID:
22695208
7.

WITHDRAWN: Interventions for dysphagia in oesophageal cancer.

Sreedharan A, Harris K, Crellin A, Forman D, Everett SM.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD005048. doi: 10.1002/14651858.CD005048.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD005048.

PMID:
21328271
8.

Interventions for dysphagia in oesophageal cancer.

Sreedharan A, Harris K, Crellin A, Forman D, Everett SM.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005048. doi: 10.1002/14651858.CD005048.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD005048.

PMID:
19821338
9.

A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer.

Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N.

N Engl J Med. 1993 Oct 28;329(18):1302-7.

10.
11.

Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer.

Touchefeu Y, Archambeaud I, Landi B, Lièvre A, Lepère C, Rougier P, Mitry E.

Dig Liver Dis. 2014 Mar;46(3):283-6. doi: 10.1016/j.dld.2013.10.012. Epub 2013 Nov 20.

PMID:
24268567
12.

Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma.

Homs MY, Steyerberg EW, Kuipers EJ, van der Gaast A, Haringsma J, van Blankenstein M, Siersema PD.

Endoscopy. 2004 Oct;36(10):880-6.

PMID:
15452784
13.

[Self-expanding metal stents for palliation of malignant oesophageal obstruction].

Tolmácsi B, Rábai K, Szamosi T, Czeglédi Z, Gyökeres T, Zsigmond F, Banai J.

Magy Seb. 2009 Apr;62(2):59-66. doi: 10.1556/MaSeb.62.2009.2.2. Hungarian.

PMID:
19386565
14.
15.

A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study.

Siersema PD, Hop WC, van Blankenstein M, van Tilburg AJ, Bac DJ, Homs MY, Kuipers EJ.

Gastrointest Endosc. 2001 Aug;54(2):145-53.

PMID:
11474382
16.

Outcomes following oesophageal stent insertion for palliation of malignant strictures: A large single centre series.

Battersby NJ, Bonney GK, Subar D, Talbot L, Decadt B, Lynch N.

J Surg Oncol. 2012 Jan;105(1):60-5. doi: 10.1002/jso.22059.

PMID:
22161899
17.

Palliative treatment of oesophageal carcinoma--efficacy of plastic versus self-expandable stents.

Sanyika C, Corr P, Haffejee A.

S Afr Med J. 1999 Jun;89(6):640-3.

PMID:
10443214
18.

Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer.

Homs MY, Steyerberg EW, Eijkenboom WM, Siersema PD; Dutch SIREC Study Group.

Brachytherapy. 2006 Jan-Mar;5(1):41-8.

PMID:
16563996
19.

Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial.

Amdal CD, Jacobsen AB, Sandstad B, Warloe T, Bjordal K.

Radiother Oncol. 2013 Jun;107(3):428-33. doi: 10.1016/j.radonc.2013.04.008. Epub 2013 May 3.

20.

Endoscopic palliation of unresectable malignant oesophageal strictures with self-expanding metal stents: comparing Ultraflex and Esophacoil stents.

Riccioni ME, Shah SK, Tringali A, Ciletti S, Mutignani M, Perri V, Zuccalà G, Coppola R, Costamagna G.

Dig Liver Dis. 2002 May;34(5):356-63.

PMID:
12118954
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk